Pediatrix Medical Group stock weighs earnings growth against soft volumes
Published on 10/06/2026 at 16:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pediatrix Medical Group (ISIN US58502B1061) was trading at USD 26.25 on the NYSE on October 6, 2026 at 9:56 a.m. ET, up USD 0.15 or 0.57 percent from the prior close. The company entered the session with Q2 2026 adjusted earnings per share of USD 0.63, compared with USD 0.53 a year earlier, according to Yahoo Finance.
Adjusted earnings outpace revenue
For Q2 2026, net revenue rose 4.0 percent year over year to USD 487.8 million, while adjusted EBITDA increased to USD 76.4 million from USD 73.2 million. The same report said adjusted EPS rose 18.9 percent from USD 0.53, showing that per-share growth exceeded the top-line increase.
The earnings mix matters because Pediatrix also repurchased USD 42.7 million of stock in Q2 2026, reducing weighted average diluted shares to 81.4 million from 85.5 million a year earlier, according to Yahoo Finance.
Volume pressure stays visible
The Q2 2026 numbers also show the central tension in the story. Hospital-based patient services fell 2.8 percent on a same-unit basis, office-based services declined 1.2 percent, and neonatal intensive care unit days dropped 3.2 percent.
Management reaffirmed full-year 2026 adjusted EBITDA guidance of USD 280 million to USD 300 million during the August 4, 2026 earnings call, while describing reimbursement, payer mix and patient acuity as the main pricing drivers, according to Yahoo Finance. The call also reported USD 126 million of operating cash flow for Q2 2026, compared with USD 138 million in the prior-year quarter.
Consensus stays close to the quote
MarketBeat lists a Hold consensus based on 6 analysts, including 1 Buy and 5 Hold ratings, with an average target of USD 26.60, a high target of USD 28.00 and a low target of USD 24.00. The average target lies 1.3 percent above the October 6, 2026 price of USD 26.25, according to MarketBeat.
The valuation backdrop is restrained rather than momentum-driven: the stock's 52-week range is USD 15.70 to USD 27.94, placing the October 6 quote USD 1.69 below the yearly high. For investors, the next test is whether reimbursement gains and buybacks can continue to offset softer patient volumes.
MD stock trades below yearly high
Pediatrix Medical Group stock was trading at USD 26.25 on the NYSE on October 6, 2026 at 9:56 a.m. ET, with a market capitalization of USD 2.2 billion and volume of 26,114 shares.
Pediatrix Medical Group stock at a glance
- Company: Pediatrix Medical Group, Inc.
- ISIN: US58502B1061
- Ticker: MD
- Trading venue: NYSE
- Price (as of October 6, 2026, 9:56 a.m. ET): USD 26.25
- Market capitalization: USD 2.2 billion (as of October 6, 2026)
- 52-week range: USD 15.70-27.94 (as of October 6, 2026)
- Sector / Industry: Healthcare / Medical Care Facilities
